Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2014 09:56 ET | Source: Afaxys Pharmaceuticals

Afaxys Pharmaceuticals Products Now Available Nationwide; OCs Placed on Pennsylvania Medicaid's Preferred Oral Contraceptives List

CHARLESTON, SC--(Marketwired - Jul 30, 2014) - Three FDA-approved oral contraceptives from Afaxys Pharmaceuticals, a division of Afaxys, Inc., (www.afaxys.com/pharma) are now preferred OCs, as per...
March 31, 2014 09:00 ET | Source: Afaxys Pharmaceuticals

HRA Pharma and Afaxys Join Forces on Emergency Contraceptive ella(R) in the USA

CHARLESTON, SC--(Marketwired - Mar 31, 2014) - HRA Pharma (www.hra-pharma.com) and Afaxys Pharmaceuticals, a division of Afaxys, Inc. (www.Afaxys.com), announced today that the companies have...
March 10, 2014 11:30 ET | Source: Afaxys Pharmaceuticals

Now Commercially Available, Lyza(TM) Creates a Stir in the Market; Public Health Providers Benefit From Low Pricing, Stable Supply

CHARLESTON, SC--(Marketwired - Mar 10, 2014) - The recent commercial coverage of a new oral contraceptive signals a possible shift in the market toward low-cost pharmaceuticals. Afaxys...
February 20, 2014 12:15 ET | Source: Afaxys Pharmaceuticals

Aubra(TM) Coverage Expands Significantly

CHARLESTON, SC--(Marketwired - Feb 20, 2014) - Afaxys Pharmaceuticals' oral contraceptive, Aubra™ /AW•bruh/ (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1mg/0.02mg) is an...
January 20, 2014 12:00 ET | Source: Nexton

The Beach Company and MWV Break Ground on "Parks at Nexton"

SUMMERVILLE, SC--(Marketwired - Jan 20, 2014) - The Beach Company and MWV have broken ground on the 320-unit Parks at Nexton apartment community. A joint venture of the two local companies, the...
October 29, 2013 13:15 ET | Source: Afaxys Pharmaceuticals

Afaxys Pharmaceuticals Introduces New Generic, Oral Contraceptive; Aubra(TM) Extends Company's Mission to Serve Safety Net Health Providers

CHARLESTON, SC--(Marketwired - Oct 29, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc. (afaxys.com), is dedicated to providing affordable health care products to the public health care...
September 04, 2013 08:24 ET | Source: Afaxys Pharmaceuticals

Afaxys Pharmaceuticals Products Now Available on MMCAP Contract, Securing Affordable OCs for Their Membership

CHARLESTON, SC--(Marketwired - Sep 4, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc., (www.afaxys.com/pharma) received FDA approval for two new oral contraceptives earlier this year,...
July 22, 2013 13:15 ET | Source: Afaxys Pharmaceuticals

Afaxys Pharmaceuticals Introduces New Generic, Oral Contraceptive

CHARLESTON, SC--(Marketwired - Jul 22, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc. (www.afaxys.com), is dedicated to providing affordable health care products to the public health...
July 01, 2013 16:58 ET | Source: Afaxys Pharmaceuticals

Chateal Coverage Expands Significantly

CHARLESTON, SC--(Marketwired - Jul 1, 2013) - Afaxys Pharmaceuticals' oral contraceptive, CHATEAL® \shah•TEEL\ (Levonorgestrel and Ethinyl Estradiol tablets USP, 0.15 mg/0.03mg) is...
April 24, 2013 09:00 ET | Source: Afaxys Pharmaceuticals

Now Commercially Available, CHATEAL(R) Creates a Stir in the Market; Public Health Providers Benefit From Low Pricing, Stable Supply From Afaxys Pharmaceuticals

CHARLESTON, SC--(Marketwired - Apr 24, 2013) - The recent commercial coverage of a new oral contraceptive heralds a possible shift in the market toward low-cost pharmaceuticals. ...

Next Page keyboard_arrow_right